PlexusDx also offers tirzepatide injection (a dual GIP/GLP-1 receptor agonist) and the novel GLP-Squared dual-compound injection, providing alternative pathways for patients seeking enhanced efficacy without additional pharmaceutical agents like naltrexone
As this issue also applies to previous studies, the overall evidence may underestimate risk
[6] Porpora MG, Brunelli R, Costa G, Imperiale L, Krasnowska EK, Lundeberg T, Nofroni I, Piccioni MG, Pittaluga E, Ticino A, Parasassi T
GLP-1 Agonists and Pancreatitis Supporting Data One meta-analysis study looking at over 14,000 participants involved in 80 trials found that there was no significant increase in the risk of pancreatitis associated with the use of GLP-1 agonist
Produced with cGMP-focused standards, quality review, and professional finished-product handling